Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies
- PMID: 18313502
- PMCID: PMC2350208
- DOI: 10.1016/S0140-6736(08)60343-8
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies
Erratum in
- Lancet. 2008 May 31;371(9627):1838
Abstract
Background: The WHO and American Diabetes Association criteria for diagnosing diabetes mellitus assume the presence of a glycaemic threshold with high sensitivity for identifying retinopathy. However, this assumption is based on data from three previous studies that had important limitations in detecting retinopathy. We aimed to provide updated data for the relation between fasting plasma glucose (FPG) and retinopathy, and to assess the diagnostic accuracy of current FPG thresholds in identifying both prevalent and incident retinopathy.
Methods: We examined the data from three cross-sectional adult populations: those in the Blue Mountains Eye Study (BMES, Australia, n=3162), the Australian Diabetes, Obesity and Lifestyle Study (AusDiab, Australia, n=2182), and the Multi-Ethnic Study of Atherosclerosis (MESA, USA, n=6079). Retinopathy was diagnosed from multiple retinal photographs of each eye, and graded according to the modified Airlie House Classification system. Plasma glucose concentrations were measured from fasting venous blood samples.
Findings: The overall prevalence of retinopathy was 11.5% in BMES (95% CI 10.4-12.6%), 9.6% in AusDiab (8.4-10.9), and 15.8% in MESA (14.9-16.7). However, we found inconsistent evidence of a uniform glycaemic threshold for prevalent and incident retinopathy, with analyses suggesting a continuous relation. The widely used diabetes FPG cutoff of 7.0 mmol/L or higher had sensitivity less than 40% (range 14.8-39.1) for detecting retinopathy, with specificity between 80.8% and 95.8%. The area under receiver operating characteristic curves for FPG and retinopathy was low and ranged from 0.56 to 0.61.
Interpretation: We saw no evidence of a clear and consistent glycaemic threshold for the presence or incidence of retinopathy across different populations. The current FPG cutoff of 7.0 mmol/L used to diagnose diabetes did not accurately identify people with and without retinopathy. These findings suggest that the criteria for diagnosing diabetes could need reassessment.
Conflict of interest statement
Conflict of interest statement
Wong had full access to all the data in the study and has final responsibility for the decision to submit the manuscript for publication. All authors state that they have no conflicts of interest.
Figures




Comment in
-
Retinopathy, plasma glucose, and the diagnosis of diabetes.Lancet. 2008 Mar 1;371(9614):700-2. doi: 10.1016/S0140-6736(08)60318-9. Lancet. 2008. PMID: 18313485 No abstract available.
References
-
- Sicree R, Shaw J, Zimmet P. The Global Burden. Diabetes and Impaired Glucose Tolerance. Prevalence and Projections. In: Gan D, editor. Diabetes Atlas. 3. Brussels: International Diabetes Federation; 2006. pp. 16–103.
-
- Lefebvre P, Silink M. Diabetes fights for recognition. Lancet. 2006 November 11;368(9548):1625–6. - PubMed
-
- World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. 2007. Available from URL: http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20....
-
- American Diabetes Association. All about diabetes. Available from URL: http://www.diabetes.org/about#diabetes.jsp.
-
- Arky RA. Doctor, is my sugar normal? N Engl J Med. 2005 October 6;353(14):1511–3. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-HC-95162/HC/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01-HC-95163/HC/NHLBI NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- R01 HL069979/HL/NHLBI NIH HHS/United States
- N01-HC-95164/HC/NHLBI NIH HHS/United States
- N01-HC-95160/HC/NHLBI NIH HHS/United States
- N01-HC-95161/HC/NHLBI NIH HHS/United States
- HL69979-03/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases